Stakeholders Take Aim at Generic Competition Blocking Tactics
August 25th 2016Generic drug manufacturers have long accused their brand name counterparts of exploiting a federal program intended to promote medication safety as a means of blocking generic competition in the pharmaceutical marketplace.